MedPath

Association Study of Gene Polymorphisms With Cardiac Performance

Conditions
Coronary Artery Disease
Genetic Polymorphism
Hemodynamics
Registration Number
NCT00730899
Lead Sponsor
University Hospital, Essen
Brief Summary

The purpose of this study is to determine whether polymorphisms in G protein subunits, namely Galphas and Galphaq, are associated with altered cardiac performance in heart failure patients.

Detailed Description

G Protein pathways plays a pivotal role in mediating positive inotropy and cardiac hypertrophy by transducing signals of neurohormones in cardiomyocytes. Single nucleotide polymorphisms (SNPs) in the G protein subunits Galphas and Galphaq have been shown to result in altered protein expression. We now want to examine whether G Protein polymorphisms alter NYHA functional class, and hemodynamic variables in patients with coronary artery disease scheduled for coronary artery bypass grafting .

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria
  • clinical diagnosis of coronary artery disease
  • patients scheduled for coronary artery bypass grafting
Exclusion Criteria
  • emergency operation
  • combined vitium

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
genotype dependent change of hemodynamic variablesone day
Secondary Outcome Measures
NameTimeMethod
all cause mortality60 days

Trial Locations

Locations (1)

University Hospital

🇩🇪

Essen, Nordrhein-Westfalen, Germany

© Copyright 2025. All Rights Reserved by MedPath